NPI: 1760426969 · WATERBURY, CT 06706 · General Acute Care Hospital · NPI assigned 06/16/2006
Authorized official HARRIS, JAMES controls 20+ related entities in our dataset. Read more
| Authorized Official | HARRIS, JAMES (REGIONAL DIRECTOR OF REIMBURSEMENT) |
| Parent Organization | TRINITY HEALTH OF NEW ENGLAND CORPORATION, INC. |
| NPI Enumeration Date | 06/16/2006 |
Other providers sharing the same authorized official: HARRIS, JAMES
| Year | Claims | Total Paid |
|---|---|---|
| 2018 | 628,504 | $24.42M |
| 2019 | 696,766 | $24.96M |
| 2020 | 612,515 | $20.31M |
| 2021 | 705,903 | $22.17M |
| 2022 | 747,144 | $23.81M |
| 2023 | 782,138 | $24.01M |
| 2024 | 733,109 | $23.60M |
| Code | Description | Claims | Beneficiaries | Total Paid |
|---|---|---|---|---|
| 99285 | Emergency department visit for the evaluation and management, high severity with immediate threat to life | 74,610 | 64,459 | $35.58M |
| 99284 | Emergency department visit for the evaluation and management, high severity | 56,687 | 50,780 | $18.17M |
| 99283 | Emergency department visit for the evaluation and management, moderate severity | 80,794 | 72,660 | $17.99M |
| G0463 | Hospital outpatient clinic visit for assessment and management of a patient | 72,902 | 62,119 | $7.29M |
| 96374 | Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance | 42,550 | 36,972 | $6.24M |
| 43239 | Esophagogastroduodenoscopy, flexible, transoral; with biopsy, single or multiple | 9,607 | 9,093 | $4.82M |
| 99282 | Emergency department visit for the evaluation and management, low to moderate severity | 21,176 | 18,348 | $2.79M |
| 74177 | Computed tomography, abdomen and pelvis; with contrast material | 14,632 | 13,270 | $2.65M |
| 45380 | Colonoscopy, flexible; with biopsy, single or multiple | 3,210 | 3,027 | $2.33M |
| 11042 | Debridement, subcutaneous tissue (includes epidermis, dermis, and subcutaneous tissue); first 20 sq cm | 14,001 | 5,846 | $2.32M |
| 99291 | Critical care, evaluation and management of the critically ill patient, first 30-74 minutes | 2,765 | 2,458 | $2.31M |
| 93306 | Echocardiography, transthoracic, real-time with image documentation, with and without Doppler, complete | 7,857 | 7,369 | $2.19M |
| 47562 | 528 | 480 | $2.15M | |
| 71046 | Radiologic examination, chest; 2 views | 37,092 | 33,440 | $2.08M |
| 45385 | Colonoscopy, flexible; with removal of tumor(s), polyp(s), or other lesion(s) | 3,601 | 3,413 | $2.04M |
| 96365 | Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour | 16,386 | 11,372 | $1.99M |
| 70450 | Computed tomography, head or brain; without contrast material | 19,809 | 17,590 | $1.97M |
| 78452 | Myocardial perfusion imaging, tomographic (SPECT); multiple studies at rest and/or stress | 2,973 | 2,767 | $1.95M |
| 96361 | Intravenous infusion, hydration; each additional hour | 31,456 | 26,124 | $1.88M |
| 97110 | Therapeutic procedure, each 15 minutes; therapeutic exercises to develop strength and endurance, flexibility and range of motion | 29,087 | 10,089 | $1.81M |
| 95810 | Polysomnography; sleep staging with 4 or more additional parameters | 2,140 | 2,062 | $1.80M |
| 45378 | Colonoscopy, flexible; diagnostic, including collection of specimen(s) | 3,030 | 2,860 | $1.77M |
| U0003 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r | 20,572 | 18,419 | $1.47M |
| 96413 | Chemotherapy administration, intravenous infusion; up to 1 hour, single or initial substance | 7,083 | 4,228 | $1.45M |
| J9271 | Injection, pembrolizumab, 1 mg | 214 | 149 | $1.40M |
| J2350 | Injection, ocrelizumab, 1 mg | 88 | 73 | $1.37M |
| 96375 | Therapeutic injection; each additional sequential IV push | 31,766 | 25,262 | $1.31M |
| 96360 | Intravenous infusion, hydration; initial, 31 minutes to 1 hour | 8,886 | 7,991 | $1.30M |
| 0241U | Neonatal screening for hereditary disorders, genomic sequence analysis panel | 10,121 | 9,433 | $1.12M |
| 99281 | Emergency department visit for the evaluation and management, self-limited or minor | 14,977 | 12,185 | $1000K |
| 77067 | Screening mammography, bilateral, including computer-aided detection | 8,764 | 8,497 | $948K |
| 93976 | 9,428 | 8,655 | $882K | |
| 95811 | 1,071 | 1,043 | $868K | |
| 97010 | 12,075 | 4,479 | $810K | |
| J0897 | Injection, denosumab, 1 mg | 1,114 | 913 | $790K |
| 76700 | Ultrasound, abdominal, real time with image documentation; complete | 7,488 | 6,986 | $737K |
| 71045 | Radiologic examination, chest; single view | 16,309 | 14,151 | $718K |
| 74176 | Computed tomography, abdomen and pelvis; without contrast material | 4,740 | 4,355 | $674K |
| 76705 | Ultrasound, abdominal, real time with image documentation; limited | 5,580 | 5,115 | $589K |
| 84443 | Thyroid stimulating hormone (TSH) | 56,938 | 51,732 | $552K |
| 82306 | Vitamin D; 25 hydroxy, includes fraction(s), if performed | 30,559 | 27,861 | $551K |
| 52356 | 168 | 156 | $548K | |
| 76856 | Ultrasound, pelvic (nonobstetric), real time with image documentation; complete | 5,718 | 5,258 | $477K |
| 86900 | 12,831 | 10,928 | $471K | |
| Q0138 | Injection, ferumoxytol, for treatment of iron deficiency anemia, 1 mg (non-esrd use) | 1,588 | 981 | $446K |
| 71260 | Computed tomography, thorax, diagnostic; with contrast material | 4,208 | 3,788 | $436K |
| 70498 | 2,036 | 1,799 | $385K | |
| 87635 | Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe | 11,108 | 9,346 | $380K |
| 70553 | Magnetic resonance imaging, brain; without contrast material, followed by contrast material and further sequences | 1,580 | 1,453 | $376K |
| 76770 | 3,475 | 3,266 | $373K | |
| 85025 | Blood count; complete (CBC), automated, and automated differential WBC count | 181,797 | 149,137 | $353K |
| 70551 | Magnetic resonance imaging, brain; without contrast material | 2,512 | 2,251 | $315K |
| 76830 | Ultrasound, transvaginal | 3,197 | 2,960 | $314K |
| 83036 | Hemoglobin; glycosylated (A1C) | 53,211 | 49,144 | $312K |
| 66984 | Extracapsular cataract removal with insertion of intraocular lens prosthesis | 644 | 512 | $298K |
| 83718 | 40,916 | 39,351 | $293K | |
| 76536 | 3,994 | 3,729 | $291K | |
| 11043 | 823 | 433 | $288K | |
| 94726 | 3,032 | 2,881 | $287K | |
| 93971 | 3,999 | 3,644 | $287K | |
| 87491 | Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe | 12,738 | 11,681 | $267K |
| 87591 | Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe | 12,739 | 11,682 | $266K |
| 82947 | 130,911 | 111,987 | $264K | |
| U0005 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within 2 calendar days from date of specimen collection (list separately in addition to either hcpcs code u0003 or u0004) as described by cms-2020-01-r2 | 12,011 | 10,865 | $260K |
| 76641 | 2,814 | 2,655 | $254K | |
| 82607 | 29,694 | 27,232 | $251K | |
| 71275 | Computed tomographic angiography, chest, with contrast material | 2,194 | 2,006 | $249K |
| 93005 | Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report | 66,566 | 56,121 | $242K |
| 96366 | Intravenous infusion, for therapy, prophylaxis, or diagnosis; each additional hour | 6,728 | 4,417 | $235K |
| C8929 | Transthoracic echocardiography with contrast, or without contrast followed by with contrast, real-time with image documentation (2d), includes m-mode recording, when performed, complete, with spectral doppler echocardiography, and with color flow doppler echocardiography | 639 | 587 | $222K |
| 76801 | 2,108 | 1,857 | $219K | |
| 93970 | 1,677 | 1,518 | $217K | |
| 72148 | Magnetic resonance imaging, lumbar spine; without contrast material | 1,399 | 1,321 | $215K |
| 0240U | 1,869 | 1,741 | $213K | |
| 94060 | 1,120 | 1,063 | $206K | |
| 82247 | 88,403 | 78,733 | $203K | |
| 95816 | 1,616 | 1,468 | $197K | |
| 76642 | 3,260 | 3,073 | $191K | |
| 82040 | 89,561 | 79,751 | $190K | |
| 72100 | 4,791 | 4,500 | $189K | |
| 77066 | Tomosynthesis, mammo | 1,560 | 1,488 | $188K |
| 73562 | 8,917 | 8,232 | $187K | |
| 36415 | Collection of venous blood by venipuncture | 196,685 | 160,844 | $185K |
| 93017 | 4,548 | 4,216 | $174K | |
| 96372 | Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular | 34,502 | 26,866 | $170K |
| 71250 | 2,874 | 2,608 | $165K | |
| 84439 | 28,524 | 26,086 | $156K | |
| S9480 | Intensive outpatient psychiatric services, per diem | 1,203 | 179 | $152K |
| 96415 | 2,057 | 1,509 | $151K | |
| H0015 | Alcohol and/or drug services; intensive outpatient (treatment program that operates at least 3 hours/day and at least 3 days/week and is based on an individualized treatment plan), including assessment, counseling; crisis intervention, and activity therapies or education | 1,154 | 192 | $147K |
| 72110 | 2,189 | 2,046 | $144K | |
| 49083 | 433 | 180 | $142K | |
| 77065 | Tomosynthesis, mammo | 1,309 | 1,233 | $140K |
| 73030 | 6,767 | 6,114 | $138K | |
| 87389 | Infectious agent antigen detection by immunoassay technique, HIV-1 antigen with HIV-1 and HIV-2 antibodies | 12,209 | 10,972 | $134K |
| 73610 | 6,681 | 5,756 | $134K | |
| 77080 | 1,358 | 1,301 | $132K | |
| 96367 | 2,750 | 1,658 | $119K | |
| 10061 | 427 | 397 | $117K | |
| 73130 | 6,061 | 5,323 | $114K | |
| 81220 | CFTR (cystic fibrosis transmembrane conductance regulator) gene analysis; common variants | 706 | 531 | $111K |
| 82728 | 18,773 | 16,743 | $108K | |
| 86480 | 2,536 | 2,349 | $107K | |
| J1439 | Injection, ferric carboxymaltose, 1 mg | 260 | 156 | $107K |
| 72141 | 839 | 762 | $106K | |
| 36430 | 760 | 528 | $102K | |
| 77063 | Screening digital breast tomosynthesis, bilateral | 7,069 | 6,843 | $100K |
| 86803 | 11,657 | 10,443 | $94K | |
| 88305 | Level IV - Surgical pathology, gross and microscopic examination | 19,232 | 17,841 | $94K |
| 83550 | 20,940 | 19,092 | $93K | |
| 80307 | Drug test(s), presumptive, any number of drug classes; immunoassay | 20,784 | 17,918 | $93K |
| 82310 | 129,859 | 110,969 | $90K | |
| 73110 | 4,111 | 3,482 | $87K | |
| 73630 | 5,713 | 5,253 | $81K | |
| 84403 | 4,174 | 3,756 | $77K | |
| 87086 | Culture, bacterial; quantitative colony count, urine | 52,639 | 46,333 | $76K |
| 76882 | 1,534 | 1,421 | $75K | |
| 73502 | 4,271 | 3,874 | $74K | |
| 73721 | Magnetic resonance imaging, any joint of lower extremity; without contrast material | 355 | 317 | $74K |
| 50590 | 30 | 28 | $74K | |
| 93225 | 1,299 | 1,235 | $72K | |
| 83540 | 21,295 | 19,423 | $71K | |
| 93458 | 58 | 52 | $70K | |
| 72050 | 879 | 807 | $70K | |
| 97161 | 1,794 | 1,578 | $69K | |
| 49650 | 16 | 15 | $68K | |
| 80061 | Lipid panel | 20,347 | 17,280 | $66K |
| 87624 | Infectious agent detection by nucleic acid; human papillomavirus (HPV), high-risk types | 2,439 | 2,333 | $65K |
| 88142 | 5,456 | 5,137 | $65K | |
| 80053 | Comprehensive metabolic panel | 30,918 | 24,350 | $62K |
| 70486 | 2,479 | 2,254 | $62K | |
| 83970 | 3,067 | 2,779 | $61K | |
| 97597 | 849 | 532 | $59K | |
| 96417 | 1,062 | 641 | $56K | |
| 87633 | Infectious agent detection by nucleic acid, respiratory virus, 12-25 targets | 2,132 | 1,947 | $56K |
| 97162 | 1,795 | 1,553 | $55K | |
| C9803 | Hospital outpatient clinic visit specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source | 17,707 | 15,727 | $54K |
| 73590 | 2,586 | 2,231 | $53K | |
| 97014 | 758 | 327 | $52K | |
| 82043 | 15,461 | 14,363 | $52K | |
| 87522 | Neg quan hep c or qual rna | 1,709 | 1,569 | $51K |
| 85027 | 27,742 | 23,382 | $49K | |
| G0103 | Prostate cancer screening; prostate specific antigen test (psa) | 4,596 | 4,202 | $49K |
| 82746 | 7,046 | 6,370 | $49K | |
| 82570 | 15,950 | 14,545 | $48K | |
| 87070 | 20,139 | 18,331 | $47K | |
| 10060 | 302 | 276 | $47K | |
| 72040 | 2,159 | 2,013 | $47K | |
| 86235 | 1,088 | 958 | $44K | |
| 93798 | 529 | 96 | $44K | |
| 93975 | 195 | 179 | $41K | |
| 73560 | 1,668 | 1,469 | $41K | |
| 19081 | 42 | 39 | $40K | |
| 72125 | Computed tomography, cervical spine; without contrast material | 6,187 | 5,461 | $40K |
| 73080 | 2,409 | 2,110 | $40K | |
| P9016 | Red blood cells, leukocytes reduced, each unit | 403 | 298 | $39K |
| 80048 | Basic metabolic panel (calcium, ionized) | 46,891 | 34,231 | $38K |
| 81329 | 665 | 471 | $38K | |
| 76805 | Ultrasound, pregnant uterus, real time with image documentation, fetal and maternal evaluation | 361 | 338 | $37K |
| 82374 | 129,972 | 111,069 | $36K | |
| 70491 | 239 | 209 | $34K | |
| 88342 | 1,128 | 1,012 | $34K | |
| 88304 | 3,569 | 3,278 | $33K | |
| 86706 | 4,605 | 4,178 | $33K | |
| 72070 | 906 | 826 | $32K | |
| 83735 | 34,529 | 25,669 | $31K | |
| 86618 | 3,968 | 3,356 | $30K | |
| 86038 | 4,355 | 3,927 | $30K | |
| 93880 | 347 | 322 | $30K | |
| J2506 | Injection, pegfilgrastim, excludes biosimilar, 0.5 mg | 48 | 36 | $30K |
| 73140 | 2,207 | 2,012 | $30K | |
| 84153 | 3,279 | 2,941 | $30K | |
| 80074 | 1,094 | 984 | $29K | |
| 43251 | 33 | 29 | $29K | |
| 86592 | 8,830 | 7,823 | $29K | |
| 84202 | 2,247 | 2,178 | $29K | |
| 87150 | 1,216 | 1,112 | $29K | |
| 74019 | 3,141 | 2,903 | $29K | |
| U0004 | 2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc, making use of high throughput technologies as described by cms-2020-01-r | 669 | 393 | $29K |
| 82465 | 41,014 | 39,433 | $29K | |
| 74018 | 2,180 | 1,971 | $28K | |
| 86003 | 492 | 436 | $27K | |
| 82652 | 919 | 875 | $27K | |
| 83655 | 2,575 | 2,506 | $27K | |
| 81003 | 47,216 | 42,031 | $27K | |
| 19301 | 12 | 12 | $26K | |
| 97165 | 496 | 437 | $26K | |
| 84702 | 11,489 | 9,638 | $26K | |
| 87661 | Infectious agent detection by nucleic acid; Trichomonas vaginalis, amplified probe | 1,841 | 1,722 | $26K |
| 97166 | 552 | 492 | $25K | |
| 84481 | 2,656 | 2,392 | $25K | |
| 87340 | 5,948 | 5,131 | $25K | |
| 73090 | 1,490 | 1,258 | $25K | |
| 84146 | 2,015 | 1,780 | $25K | |
| 87186 | 12,246 | 10,991 | $24K | |
| 82105 | 2,185 | 1,975 | $23K | |
| 83001 | 1,820 | 1,582 | $23K | |
| 83525 | 2,644 | 2,413 | $23K | |
| 84480 | 2,582 | 2,354 | $23K | |
| J2505 | Injection, pegfilgrastim, 6 mg | 21 | 14 | $22K |
| 84402 | 1,192 | 1,072 | $21K | |
| G0480 | Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 1-7 drug class(es), including metabolite(s) if performed | 5,515 | 4,807 | $20K |
| 84270 | 1,193 | 1,066 | $20K | |
| 59025 | Fetal non-stress test | 131 | 114 | $19K |
| 83002 | 1,464 | 1,266 | $19K | |
| 85610 | 35,555 | 29,758 | $19K | |
| 87338 | 1,769 | 1,613 | $18K | |
| 77085 | 302 | 292 | $18K | |
| 74183 | 72 | 69 | $18K | |
| 69436 | Tympanostomy (requiring insertion of ventilating tube), general anesthesia | 15 | 15 | $18K |
| 78306 | 87 | 79 | $17K | |
| 92507 | Treatment of speech, language, voice, communication, and/or auditory processing disorder | 195 | 54 | $17K |
| 93923 | 311 | 291 | $17K | |
| 87536 | 305 | 276 | $17K | |
| J2469 | Injection, palonosetron hcl, 25 mcg | 1,701 | 954 | $16K |
| 82784 | 2,659 | 2,283 | $16K | |
| 72131 | 303 | 283 | $16K | |
| 97530 | Therapeutic activities, direct patient contact, each 15 minutes | 304 | 217 | $15K |
| 77062 | 1,048 | 993 | $14K | |
| 86376 | 1,798 | 1,604 | $14K | |
| 83520 | 1,299 | 1,224 | $14K | |
| 82670 | 756 | 661 | $14K | |
| 74220 | 127 | 121 | $14K | |
| 86140 | 10,548 | 9,563 | $14K | |
| 82951 | 1,261 | 1,173 | $14K | |
| G0399 | Home sleep test (hst) with type iii portable monitor, unattended; minimum of 4 channels: 2 respiratory movement/airflow, 1 ecg/heart rate and 1 oxygen saturation | 134 | 120 | $13K |
| 73221 | 67 | 63 | $13K | |
| 85652 | 11,064 | 9,947 | $13K | |
| 86762 | 3,335 | 2,739 | $12K | |
| 97035 | 182 | 94 | $12K | |
| 86200 | 1,790 | 1,656 | $12K | |
| 83880 | 10,407 | 9,285 | $12K | |
| 87798 | Infectious agent detection by nucleic acid; not otherwise specified, amplified probe, each organism | 401 | 371 | $12K |
| 87088 | 5,283 | 4,773 | $12K | |
| 72170 | 1,696 | 1,527 | $11K | |
| 87077 | 6,418 | 5,788 | $11K | |
| 85730 | 9,214 | 7,866 | $11K | |
| 86225 | 1,299 | 1,175 | $11K | |
| 80076 | 18,418 | 14,817 | $10K | |
| 87506 | 98 | 91 | $10K | |
| 86160 | 752 | 686 | $10K | |
| 70496 | 1,123 | 995 | $9K | |
| 83516 | 1,457 | 1,151 | $9K | |
| 86364 | 825 | 757 | $9K | |
| 81001 | 15,873 | 14,156 | $9K | |
| 86800 | 1,046 | 953 | $9K | |
| 86696 | 625 | 589 | $9K | |
| 82533 | 1,034 | 863 | $9K | |
| 73551 | 577 | 518 | $9K | |
| 83690 | 41,453 | 36,111 | $9K | |
| 78014 | 28 | 27 | $9K | |
| 86430 | 2,806 | 2,588 | $8K | |
| 71101 | 778 | 717 | $8K | |
| 83993 | 610 | 529 | $8K | |
| 78264 | 25 | 25 | $8K | |
| G0121 | Colorectal cancer screening; colonoscopy on individual not meeting criteria for high risk | 12 | 12 | $8K |
| 86920 | 751 | 591 | $8K | |
| 86787 | 741 | 684 | $8K | |
| 88112 | 373 | 325 | $7K | |
| 87147 | 4,632 | 4,307 | $7K | |
| 88307 | 665 | 604 | $6K | |
| 86695 | 625 | 589 | $6K | |
| 82627 | 387 | 340 | $6K | |
| G0379 | Direct admission of patient for hospital observation care | 12 | 12 | $6K |
| 97116 | 135 | 110 | $6K | |
| 82248 | 38,687 | 34,632 | $6K | |
| 86765 | 589 | 540 | $6K | |
| 90675 | 24 | 12 | $6K | |
| 86769 | 163 | 154 | $6K | |
| 73060 | 516 | 454 | $6K | |
| 86255 | 685 | 576 | $6K | |
| 87493 | 323 | 280 | $6K | |
| 86334 | 1,028 | 876 | $6K | |
| 84165 | 2,193 | 1,859 | $6K | |
| 86735 | 535 | 488 | $6K | |
| 86704 | 807 | 695 | $5K | |
| 96411 | 87 | 55 | $5K | |
| 90686 | 338 | 322 | $5K | |
| 73564 | 90 | 84 | $5K | |
| 12011 | 1,650 | 1,522 | $5K | |
| 80164 | 1,087 | 909 | $5K | |
| 82785 | 429 | 382 | $5K | |
| 12001 | 2,285 | 2,132 | $5K | |
| 82150 | 2,309 | 2,035 | $5K | |
| 86141 | 825 | 749 | $5K | |
| 41899 | Unlisted procedure, dentoalveolar structures | 34 | 27 | $4K |
| 86360 | 144 | 129 | $4K | |
| 84156 | 2,576 | 2,216 | $4K | |
| 94010 | 1,723 | 1,634 | $4K | |
| 84207 | 288 | 258 | $4K | |
| 87075 | 3,988 | 3,234 | $4K | |
| G0378 | Hospital observation service, per hour | 11,338 | 9,086 | $4K |
| 73700 | 60 | 55 | $3K | |
| 87427 | 602 | 545 | $3K | |
| 83020 | 1,556 | 1,153 | $3K | |
| 77061 | 247 | 234 | $3K | |
| 84450 | 91,533 | 81,562 | $3K | |
| 88173 | 1,067 | 930 | $3K | |
| 82550 | 7,932 | 6,948 | $3K | |
| 87400 | 6,945 | 6,403 | $3K | |
| 81376 | 15 | 12 | $3K | |
| 29515 | 28 | 24 | $3K | |
| 83630 | 233 | 183 | $3K | |
| 87328 | 376 | 345 | $3K | |
| J0185 | Injection, aprepitant, 1 mg | 46 | 25 | $3K |
| 83521 | 909 | 764 | $3K | |
| 87045 | 602 | 545 | $3K | |
| 73100 | 42 | 36 | $3K | |
| 84478 | 41,044 | 39,432 | $3K | |
| 87046 | 601 | 545 | $3K | |
| 0011A | 358 | 183 | $3K | |
| 82565 | 132,567 | 113,269 | $3K | |
| 82140 | 1,260 | 1,042 | $3K | |
| 87329 | 352 | 321 | $3K | |
| 73660 | 359 | 328 | $3K | |
| 85045 | 3,261 | 2,876 | $2K | |
| 86258 | 161 | 141 | $2K | |
| 85379 | 7,734 | 6,962 | $2K | |
| 85018 | 3,085 | 2,466 | $2K | |
| 86850 | 12,646 | 10,768 | $2K | |
| 85014 | 2,886 | 2,285 | $2K | |
| 87205 | 3,689 | 2,971 | $2K | |
| 83010 | 876 | 759 | $2K | |
| 12002 | 563 | 525 | $2K | |
| 82523 | 210 | 190 | $2K | |
| 86780 | 172 | 170 | $2K | |
| 92950 | 13 | 13 | $2K | |
| 76857 | 112 | 106 | $2K | |
| 86381 | 118 | 100 | $2K | |
| 81025 | 15,448 | 14,100 | $2K | |
| 94618 | 285 | 268 | $2K | |
| P9604 | Travel allowance one way in connection with medically necessary laboratory specimen collection drawn from home bound or nursing home bound patient; prorated trip charge | 1,953 | 1,231 | $2K |
| 83090 | 205 | 175 | $2K | |
| 86617 | 233 | 196 | $2K | |
| 97112 | Therapeutic procedure, each 15 minutes; neuromuscular reeducation of movement, balance, coordination | 47 | 27 | $2K |
| 76817 | Ultrasound, pregnant uterus, real time with image documentation, transvaginal | 1,097 | 973 | $2K |
| 84550 | 3,657 | 3,235 | $2K | |
| 97140 | Manual therapy techniques, each 15 minutes (e.g., mobilization/manipulation, manual lymphatic drainage) | 161 | 71 | $2K |
| 36591 | 27 | 24 | $1K | |
| 83721 | 259 | 222 | $1K | |
| 80178 | 410 | 357 | $1K | |
| 83883 | 485 | 394 | $1K | |
| 96402 | 88 | 65 | $1K | |
| 90471 | Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine | 6,036 | 5,234 | $1K |
| 76816 | Ultrasound, pregnant uterus, real time with image documentation, follow-up | 13 | 12 | $1K |
| 86355 | 144 | 129 | $1K | |
| 86359 | 144 | 129 | $1K | |
| 86357 | 144 | 129 | $1K | |
| 82378 | 846 | 655 | $1K | |
| 74241 | 14 | 13 | $1K | |
| 87040 | 11,152 | 9,486 | $1K | |
| 86705 | 156 | 127 | $975.77 | |
| 0004A | 27 | 26 | $965.87 | |
| 84100 | 14,888 | 11,020 | $934.78 | |
| 90715 | 4,599 | 4,282 | $913.50 | |
| 84460 | 91,281 | 81,412 | $890.57 | |
| 83498 | 44 | 40 | $886.94 | |
| 87653 | 28 | 28 | $871.26 | |
| 86901 | 12,832 | 10,929 | $853.50 | |
| 86709 | 119 | 96 | $829.49 | |
| 84484 | 39,155 | 32,187 | $819.99 | |
| 86015 | 101 | 87 | $763.76 | |
| 86694 | 65 | 63 | $761.19 | |
| 87081 | 146 | 141 | $760.80 | |
| 84132 | 131,319 | 112,121 | $746.44 | |
| 82977 | 946 | 860 | $744.18 | |
| 86708 | 97 | 85 | $733.46 | |
| 82653 | 76 | 75 | $726.33 | |
| 82435 | 129,974 | 111,071 | $725.50 | |
| 81596 | 31 | 29 | $717.42 | |
| 82805 | 2,021 | 1,784 | $716.14 | |
| 87651 | Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe | 1,799 | 1,722 | $691.15 |
| 84080 | 98 | 90 | $677.76 | |
| 83605 | 13,779 | 11,436 | $650.32 | |
| 84590 | 92 | 81 | $648.82 | |
| 86231 | 83 | 71 | $646.97 | |
| J2359 | Injection, olanzapine, 0.5 mg | 52 | 45 | $644.54 |
| 84410 | 12 | 12 | $609.48 | |
| 0001A | 90 | 42 | $602.23 | |
| 96376 | 9,755 | 6,561 | $596.07 | |
| 82705 | 157 | 145 | $587.25 | |
| 83615 | 4,028 | 3,253 | $575.93 | |
| 82390 | 79 | 68 | $570.43 | |
| 76981 | 13 | 13 | $568.08 | |
| 51701 | 2,813 | 2,561 | $555.39 | |
| 76377 | 7,463 | 6,624 | $551.43 | |
| 84630 | 58 | 56 | $489.15 | |
| 86665 | 44 | 39 | $484.96 | |
| 80051 | 237 | 217 | $443.06 | |
| 0064A | 13 | 13 | $440.00 | |
| 87529 | 67 | 65 | $435.63 | |
| 86308 | 580 | 540 | $429.23 | |
| 16020 | 29 | 24 | $428.03 | |
| 86039 | 63 | 63 | $426.40 | |
| 82103 | 46 | 40 | $411.53 | |
| 82656 | 51 | 45 | $394.70 | |
| 86304 | 40 | 39 | $384.63 | |
| 87625 | 14 | 12 | $371.76 | |
| 73522 | 15 | 15 | $358.59 | |
| J3490 | Unclassified drugs | 74,835 | 37,261 | $325.64 |
| J2310 | Injection, naloxone hydrochloride, per 1 mg | 71 | 65 | $319.99 |
| 82077 | 6,277 | 5,459 | $314.72 | |
| 94640 | Pressurized or nonpressurized inhalation treatment for acute airway obstruction | 4,303 | 3,662 | $306.32 |
| 82088 | 12 | 12 | $305.80 | |
| 84520 | 132,005 | 112,833 | $295.81 | |
| 86664 | 42 | 39 | $292.20 | |
| 73552 | 14 | 14 | $288.15 | |
| 83695 | 27 | 27 | $274.18 | |
| 76870 | 1,241 | 1,159 | $271.90 | |
| 84255 | 14 | 13 | $268.18 | |
| 89051 | 783 | 489 | $262.56 | |
| 86812 | 15 | 12 | $246.50 | |
| 29125 | 52 | 49 | $221.03 | |
| 84075 | 88,441 | 78,812 | $213.71 | |
| 82495 | 14 | 13 | $213.07 | |
| 82330 | 838 | 765 | $211.34 | |
| 87807 | 1,474 | 1,412 | $209.97 | |
| 84425 | 12 | 12 | $206.33 | |
| 83921 | 17 | 17 | $204.36 | |
| 93041 | 4,609 | 4,231 | $160.93 | |
| 86677 | 32 | 31 | $152.46 | |
| 80185 | 37 | 29 | $139.26 | |
| 86431 | 39 | 38 | $135.50 | |
| 84466 | 14 | 13 | $134.09 | |
| 80177 | 52 | 48 | $125.41 | |
| 87880 | Infectious agent antigen detection by immunoassay; Streptococcus, group A | 4,903 | 4,689 | $101.70 |
| 86663 | 15 | 14 | $100.24 | |
| 84295 | 130,056 | 111,124 | $98.91 | |
| 83918 | 15 | 14 | $94.32 | |
| J0131 | Injection, acetaminophen, not otherwise specified,10 mg | 939 | 809 | $81.41 |
| 84155 | 88,159 | 78,565 | $63.74 | |
| 86300 | 141 | 102 | $59.61 | |
| 88300 | 13 | 12 | $55.32 | |
| J1170 | Injection, hydromorphone, up to 4 mg | 14,794 | 9,196 | $55.30 |
| 87502 | Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets | 38 | 36 | $51.88 |
| 80047 | 151 | 127 | $51.64 | |
| 82553 | 1,412 | 1,262 | $50.83 | |
| 82948 | 4,438 | 3,920 | $50.36 | |
| 81243 | 770 | 579 | $42.59 | |
| 86403 | 5,015 | 4,662 | $38.63 | |
| 84703 | 12 | 12 | $35.90 | |
| 88312 | 9,059 | 8,557 | $34.60 | |
| 82232 | 29 | 26 | $33.67 | |
| 99152 | 1,641 | 1,495 | $33.29 | |
| 87076 | 14 | 12 | $30.88 | |
| J1100 | Injection, dexamethasone sodium phosphate, 1 mg | 23,404 | 19,888 | $29.39 |
| 83935 | 14 | 12 | $28.36 | |
| J1885 | Injection, ketorolac tromethamine, per 15 mg | 35,575 | 31,009 | $28.10 |
| 80143 | 758 | 672 | $26.84 | |
| J2704 | Injection, propofol, 10 mg | 37,905 | 26,837 | $26.02 |
| J0736 | Injection, clindamycin phosphate, 300 mg | 22 | 13 | $25.46 |
| 83930 | 15 | 13 | $25.24 | |
| Q9967 | Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml | 24,249 | 21,704 | $23.50 |
| 51798 | 14 | 12 | $22.56 | |
| J2270 | Injection, morphine sulfate, up to 10 mg | 7,435 | 5,978 | $21.88 |
| J2405 | Injection, ondansetron hydrochloride, per 1 mg | 31,526 | 26,529 | $19.73 |
| J0696 | Injection, ceftriaxone sodium, per 250 mg | 7,634 | 5,957 | $19.18 |
| 81002 | 4,874 | 4,461 | $16.69 | |
| C1894 | Introducer/sheath, other than guiding, other than intracardiac electrophysiological, non-laser | 1,310 | 1,204 | $13.65 |
| 80179 | 715 | 641 | $13.42 | |
| 71100 | 12 | 12 | $12.49 | |
| J2930 | Injection, methylprednisolone sodium succinate, up to 125 mg | 2,771 | 2,373 | $9.11 |
| J1644 | Injection, heparin sodium, per 1000 units | 9,365 | 4,576 | $8.32 |
| 99153 | Mod sedat endo service >5yrs | 1,372 | 1,250 | $7.22 |
| 82962 | 2,587 | 1,172 | $6.87 | |
| C9113 | Injection, pantoprazole sodium, per vial | 3,006 | 1,896 | $6.70 |
| J0690 | Injection, cefazolin sodium, 500 mg | 9,729 | 7,826 | $6.62 |
| J1953 | Injection, levetiracetam, 10 mg | 310 | 241 | $5.34 |
| J0665 | Injection, bupivicaine, not otherwise specified, 0.5 mg | 1,756 | 1,538 | $4.65 |
| J7512 | Prednisone, immediate release or delayed release, oral, 1 mg | 5,177 | 4,340 | $3.21 |
| J1200 | Injection, diphenhydramine hcl, up to 50 mg | 7,613 | 6,217 | $2.72 |
| 70360 | 27 | 24 | $2.70 | |
| J2250 | Injection, midazolam hydrochloride, per 1 mg | 16,460 | 14,833 | $2.45 |
| J7120 | Ringers lactate infusion, up to 1000 cc | 473 | 448 | $2.42 |
| J2765 | Injection, metoclopramide hcl, up to 10 mg | 4,905 | 4,376 | $2.42 |
| J3010 | Injection, fentanyl citrate, 0.1 mg | 18,338 | 16,493 | $2.25 |
| J3475 | Injection, magnesium sulfate, per 500 mg | 6,889 | 4,497 | $2.07 |
| G8979 | Mobility: walking & moving around functional limitation, projected goal status, at therapy episode outset, at reporting intervals, and at discharge or to end reporting | 546 | 478 | $1.71 |
| G8978 | Mobility: walking & moving around functional limitation, current status, at therapy episode outset and at reporting intervals | 496 | 442 | $1.55 |
| J3480 | Injection, potassium chloride, per 2 meq | 1,868 | 1,347 | $1.10 |
| G8988 | Self care functional limitation, projected goal status, at therapy episode outset, at reporting intervals, and at discharge or to end reporting | 342 | 298 | $1.05 |
| J2550 | Injection, promethazine hcl, up to 50 mg | 277 | 248 | $1.00 |
| J1630 | Injection, haloperidol, up to 5 mg | 2,706 | 2,326 | $1.00 |
| G8987 | Self care functional limitation, current status, at therapy episode outset and at reporting intervals | 326 | 283 | $0.97 |
| J1940 | Injection, furosemide, up to 20 mg | 1,052 | 777 | $0.80 |
| G0475 | Hiv antigen/antibody, combination assay, screening | 880 | 778 | $0.77 |
| J1650 | Injection, enoxaparin sodium, 10 mg | 3,585 | 2,149 | $0.66 |
| J8540 | Dexamethasone, oral, 0.25 mg | 475 | 380 | $0.27 |
| J2060 | Injection, lorazepam, 2 mg | 4,165 | 3,365 | $0.26 |
| J1836 | Injection, metronidazole, 10 mg | 112 | 52 | $0.25 |
| G8980 | Mobility: walking & moving around functional limitation, discharge status, at discharge from therapy or to end reporting | 13 | 13 | $0.03 |
| 93226 | 1,299 | 1,235 | $0.00 | |
| J3370 | Injection, vancomycin hcl, 500 mg | 2,206 | 1,448 | $0.00 |
| 51702 | 145 | 129 | $0.00 | |
| J0171 | Injection, adrenalin, epinephrine, 0.1 mg | 2,800 | 2,240 | $0.00 |
| J1171 | Injection, hydromorphone, 0.1 mg | 328 | 248 | $0.00 |
| C1713 | Anchor/screw for opposing bone-to-bone or soft tissue-to-bone (implantable) | 390 | 353 | $0.00 |
| J0780 | Injection, prochlorperazine, up to 10 mg | 476 | 425 | $0.00 |
| Q0163 | Diphenhydramine hydrochloride, 50 mg, oral, fda approved prescription anti-emetic, for use as a complete therapeutic substitute for an iv anti-emetic at time of chemotherapy treatment not to exceed a 48 hour dosage regimen | 2,649 | 2,128 | $0.00 |
| Q9950 | Injection, sulfur hexafluoride lipid microspheres, per ml | 199 | 186 | $0.00 |
| A9575 | Injection, gadoterate meglumine, 0.1 ml | 2,869 | 2,577 | $0.00 |
| 94729 | 2,998 | 2,849 | $0.00 | |
| J2919 | Injection, methylprednisolone sodium succinate, 5 mg | 439 | 304 | $0.00 |
| 90714 | 64 | 54 | $0.00 | |
| J3486 | Injection, ziprasidone mesylate, 10 mg | 50 | 39 | $0.00 |
| 88313 | 2,206 | 2,075 | $0.00 | |
| Q0177 | Hydroxyzine pamoate, 25 mg, oral, fda approved prescription anti-emetic, for use as a complete therapeutic substitute for an iv anti-emetic at the time of chemotherapy treatment, not to exceed a 48 hour dosage regimen | 1,810 | 1,236 | $0.00 |
| J1756 | Injection, iron sucrose, 1 mg | 2,352 | 977 | $0.00 |
| 82272 | 143 | 138 | $0.00 | |
| J0694 | Injection, cefoxitin sodium, 1 gm | 815 | 419 | $0.00 |
| J7510 | Prednisolone oral, per 5 mg | 97 | 94 | $0.00 |
| 69209 | 116 | 93 | $0.00 | |
| J1596 | Injection, glycopyrrolate, 0.1 mg | 222 | 194 | $0.00 |
| A9531 | Iodine i-131 sodium iodide, diagnostic, per microcurie (up to 100 microcuries) | 14 | 14 | $0.00 |
| A9541 | Technetium tc-99m sulfur colloid, diagnostic, per study dose, up to 20 millicuries | 170 | 160 | $0.00 |
| J2710 | Injection, neostigmine methylsulfate, up to 0.5 mg | 561 | 490 | $0.00 |
| 87804 | Infectious agent antigen detection by immunoassay; Influenza, each type | 2,201 | 2,010 | $0.00 |
| S0077 | Injection, clindamycin phosphate, 300 mg | 199 | 173 | $0.00 |
| 95957 | 35 | 32 | $0.00 | |
| 76942 | 45 | 43 | $0.00 | |
| J7030 | Infusion, normal saline solution , 1000 cc | 371 | 332 | $0.00 |
| J1453 | Injection, fosaprepitant, 1 mg | 90 | 55 | $0.00 |
| G0279 | Diagnostic digital breast tomosynthesis, unilateral or bilateral (list separately in addition to 77065 or 77066) | 15 | 15 | $0.00 |
| C1887 | Catheter, guiding (may include infusion/perfusion capability) | 57 | 51 | $0.00 |
| 76376 | 108 | 96 | $0.00 | |
| 81206 | 119 | 94 | $0.00 | |
| Q9957 | Injection, perflutren lipid microspheres, per ml | 142 | 135 | $0.00 |
| J1580 | Injection, garamycin, gentamicin, up to 80 mg | 94 | 75 | $0.00 |
| J7040 | Infusion, normal saline solution, sterile (500 ml = 1 unit) | 59 | 45 | $0.00 |
| J0702 | Injection, betamethasone acetate 3 mg and betamethasone sodium phosphate 3 mg | 18 | 12 | $0.00 |
| 84112 | 12 | 12 | $0.00 | |
| J3489 | Injection, zoledronic acid, 1 mg | 15 | 13 | $0.00 |
| 91300 | 83 | 72 | $0.00 | |
| 81401 | 24 | 24 | $0.00 | |
| 82800 | 14 | 13 | $0.00 | |
| 77002 | 12 | 12 | $0.00 | |
| J2272 | Injection, morphine sulfate (fresenius kabi), not therapeutically equivalent to j2270, up to 10 mg | 19 | 16 | $0.00 |
| 97803 | 46 | 44 | $0.00 | |
| 84145 | 12 | 12 | $0.00 | |
| C1776 | Joint device (implantable) | 16 | 15 | $0.00 |
| C1769 | Guide wire | 2,748 | 2,505 | $0.00 |
| C1781 | Mesh (implantable) | 659 | 605 | $0.00 |
| 83009 | 4,071 | 3,841 | $0.00 | |
| J2370 | Injection, phenylephrine hcl, up to 1 ml | 2,321 | 1,907 | $0.00 |
| Q3014 | Telehealth originating site facility fee | 186 | 172 | $0.00 |
| J2001 | Injection, lidocaine hcl for intravenous infusion, 10 mg | 3,206 | 2,781 | $0.00 |
| J3420 | Injection, vitamin b-12 cyanocobalamin, up to 1000 mcg | 3,346 | 2,652 | $0.00 |
| 96368 | 294 | 222 | $0.00 | |
| A9500 | Technetium tc-99m sestamibi, diagnostic, per study dose | 3,052 | 2,837 | $0.00 |
| J2003 | Injection, lidocaine hydrochloride, 1 mg | 414 | 358 | $0.00 |
| J2795 | Injection, ropivacaine hydrochloride, 1 mg | 572 | 528 | $0.00 |
| V2632 | Posterior chamber intraocular lens | 543 | 433 | $0.00 |
| 94760 | 2,491 | 2,379 | $0.00 | |
| J2785 | Injection, regadenoson, 0.1 mg | 1,682 | 1,568 | $0.00 |
| J1030 | Injection, methylprednisolone acetate, 40 mg | 20 | 14 | $0.00 |
| 11045 | 2,539 | 1,263 | $0.00 | |
| J0330 | Injection, succinylcholine chloride, up to 20 mg | 301 | 270 | $0.00 |
| 84157 | 17 | 12 | $0.00 | |
| J2360 | Injection, orphenadrine citrate, up to 60 mg | 849 | 756 | $0.00 |
| J3411 | Injection, thiamine hcl, 100 mg | 1,118 | 830 | $0.00 |
| 88341 | 346 | 313 | $0.00 | |
| J2305 | Injection, nitroglycerin, 5 mg | 32 | 26 | $0.00 |
| A9585 | Injection, gadobutrol, 0.1 ml | 510 | 450 | $0.00 |
| A9503 | Technetium tc-99m medronate, diagnostic, per study dose, up to 30 millicuries | 130 | 122 | $0.00 |
| J2920 | Injection, methylprednisolone sodium succinate, up to 40 mg | 127 | 70 | $0.00 |
| 0352U | 68 | 65 | $0.00 | |
| J0500 | Injection, dicyclomine hcl, up to 20 mg | 531 | 511 | $0.00 |
| J0713 | Injection, ceftazidime, per 500 mg | 42 | 36 | $0.00 |
| C2617 | Stent, non-coronary, temporary, without delivery system | 289 | 275 | $0.00 |
| A4648 | Tissue marker, implantable, any type, each | 41 | 38 | $0.00 |
| J2470 | Injection, pantoprazole sodium, 40 mg | 202 | 110 | $0.00 |
| G0472 | Hepatitis c antibody screening, for individual at high risk and other covered indication(s) | 191 | 189 | $0.00 |
| 85660 | 14 | 12 | $0.00 | |
| J9045 | Injection, carboplatin, 50 mg | 43 | 26 | $0.00 |
| 88311 | 68 | 62 | $0.00 | |
| J2371 | Injection, phenylephrine hydrochloride, 20 micrograms | 753 | 610 | $0.00 |
| J0456 | Injection, azithromycin, 500 mg | 39 | 27 | $0.00 |
| J1815 | Injection, insulin, per 5 units | 24 | 18 | $0.00 |
| C9290 | Injection, bupivacaine liposome, 1 mg | 63 | 61 | $0.00 |
| J0280 | Injection, aminophyllin, up to 250 mg | 40 | 37 | $0.00 |
| J7050 | Infusion, normal saline solution, 250 cc | 61 | 47 | $0.00 |
| 96377 | 71 | 50 | $0.00 | |
| 91306 | 13 | 13 | $0.00 | |
| C1726 | Catheter, balloon dilatation, non-vascular | 12 | 12 | $0.00 |
| C1819 | Surgical tissue localization and excision device (implantable) | 13 | 13 | $0.00 |
| 94644 | 16 | 14 | $0.00 | |
| A9512 | Technetium tc-99m pertechnetate, diagnostic, per millicurie | 14 | 14 | $0.00 |
| J9267 | Injection, paclitaxel, 1 mg | 58 | 24 | $0.00 |
| 91301 | 188 | 175 | $0.00 | |
| Q9963 | High osmolar contrast material, 350-399 mg/ml iodine concentration, per ml | 15 | 13 | $0.00 |
| C1766 | Introducer/sheath, guiding, intracardiac electrophysiological, steerable, other than peel-away | 16 | 14 | $0.00 |